These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15265276)

  • 1. The relationships between atherosclerosis, heart disease, type 2 diabetes and dementia.
    Messier C; Awad N; Gagnon M
    Neurol Res; 2004 Jul; 26(5):567-72. PubMed ID: 15265276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease.
    Tiehuis AM; van der Graaf Y; Visseren FL; Vincken KL; Biessels GJ; Appelman AP; Kappelle LJ; Mali WP;
    Stroke; 2008 May; 39(5):1600-3. PubMed ID: 18369167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations.
    Allen KV; Frier BM; Strachan MW
    Eur J Pharmacol; 2004 Apr; 490(1-3):169-75. PubMed ID: 15094083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function.
    Awad N; Gagnon M; Messier C
    J Clin Exp Neuropsychol; 2004 Nov; 26(8):1044-80. PubMed ID: 15590460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized atherosclerosis, cognitive decline, and depressive symptoms in old age.
    Vinkers DJ; Stek ML; van der Mast RC; de Craen AJ; Le Cessie S; Jolles J; Westendorp RG; Gussekloo J
    Neurology; 2005 Jul; 65(1):107-12. PubMed ID: 16009894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, cognitive decline, and dementia: an epidemiological perspective.
    Tzourio C
    Dialogues Clin Neurosci; 2007; 9(1):61-70. PubMed ID: 17506226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort.
    Knopman DS; Mosley TH; Catellier DJ; Sharrett AR;
    Neurology; 2005 Sep; 65(6):876-81. PubMed ID: 16186527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial.
    Peters R; Poulter R; Beckett N; Forette F; Fagard R; Potter J; Swift C; Anderson C; Fletcher A; Bulpitt CJ
    J Hypertens; 2009 Oct; 27(10):2055-62. PubMed ID: 19696686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study.
    Mosley TH; Knopman DS; Catellier DJ; Bryan N; Hutchinson RG; Grothues CA; Folsom AR; Cooper LS; Burke GL; Liao D; Szklo M
    Neurology; 2005 Jun; 64(12):2056-62. PubMed ID: 15985571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the metabolic syndrome with intracranial atherosclerotic stroke.
    Bang OY; Kim JW; Lee JH; Lee MA; Lee PH; Joo IS; Huh K
    Neurology; 2005 Jul; 65(2):296-8. PubMed ID: 16043803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study.
    Bruce DG; Davis WA; Starkstein SE; Davis TM
    J Alzheimers Dis; 2014; 42 Suppl 3():S63-70. PubMed ID: 24840567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors.
    Reijmer YD; van den Berg E; de Bresser J; Kessels RP; Kappelle LJ; Algra A; Biessels GJ;
    Diabetes Metab Res Rev; 2011 Feb; 27(2):195-202. PubMed ID: 21294241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.
    Barnes DE; Alexopoulos GS; Lopez OL; Williamson JD; Yaffe K
    Arch Gen Psychiatry; 2006 Mar; 63(3):273-9. PubMed ID: 16520432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonian signs in subjects with mild cognitive impairment.
    Boyle PA; Wilson RS; Aggarwal NT; Arvanitakis Z; Kelly J; Bienias JL; Bennett DA
    Neurology; 2005 Dec; 65(12):1901-6. PubMed ID: 16380610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, diabetes and cognitive deficit: The Framingham Heart Study.
    Elias MF; Elias PK; Sullivan LM; Wolf PA; D'Agostino RB
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():11-6. PubMed ID: 16223549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort.
    Dolan H; Crain B; Troncoso J; Resnick SM; Zonderman AB; Obrien RJ
    Ann Neurol; 2010 Aug; 68(2):231-40. PubMed ID: 20695015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between insulin resistance and intracranial atherosclerosis in patients with ischemic stroke without diabetes.
    Park HY; Kyeong-Ho ; Park DS; Lee HS; Chang H; Kim YS; Cho KH
    J Stroke Cerebrovasc Dis; 2008; 17(6):401-5. PubMed ID: 18984435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease.
    Deschaintre Y; Richard F; Leys D; Pasquier F
    Neurology; 2009 Sep; 73(9):674-80. PubMed ID: 19720973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism.
    Jellinger KA; Attems J
    Acta Neurol Scand; 2006 Jul; 114(1):38-46. PubMed ID: 16774626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging.
    Messier C
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():26-30. PubMed ID: 16236384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.